Buscar

01/05/2025 Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study
Cote, A, Mosnaim, GS, Lugogo, NL, Price, D, Plaza, V, Changming, X, Awad, H, Kwah, J. Dupilumab Improves Health-related Quality of Life and Asthma Control in Patients With and Without Coexisting Type 2 Conditions: Results From the RAPID Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 211DOI:10.1164/ajrccm.2025.211.Abstracts.A1399. PMID:. IF:19.400(Q1/1D).
01/04/2025 Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry
Oscullo, G, Méndez, R, Olveira, C, Girón, R, García-Clemente, M, Máiz, L, Sibila, O, Golpe, R, Rodríguez-Hermosa, J, Barreiro, E, Prados, C, Rodríguez-López, JL, de la Rosa-carrillo, D, Martinez-García, MA. Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2025.02.015. PMID:40180519. IF:9.200(Q1/1D).
01/04/2025 Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study
Zapater, A, Pinilla, L, Gracia-Lavedan, E, Targa, A, Torres, G, Mínguez, O, Pascual, L, Cortijo, A, Martínez, D, Benítez, ID, García-Hidalgo, MC, De Batlle, J, Abad, J, Duran-Cantolla, J, Urrutia, A, Mediano, O, Masdeu, MJ, Ordax-Carbajo, E, Masa, JF, De la Peña, M, Mayos, M, Coloma, R, Montserrat, JM, Chiner, E, Roncero, A, Sanz-Rubio, D, Barbé, F, Sánchez-de-la-Torre, M. Unraveling the Molecular Mechanisms of OSA-Related Cardiovascular Event Recurrence: A Post Hoc Analysis From the ISAACC Study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(4)DOI:10.1016/j.arbres.2024.09.008. PMID:39438203. IF:9.200(Q1/1D).
01/04/2025 Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial
Bermudo-Peloche, G, Del Rio, B, Vicens-Zygmunt, V, Bordas-Martinez, J, Hernández, M, Valenzuela, C, Laporta, R, Bobillo, JR, Portillo, K, Millán-Billi, P, Balcells, E, Badenes-Bonet, D, Bolivar, S, Rodríguez-Portal, JA, Ramirez, CL, Tomás, L, Roitegi, KFD, Sellarés, J, Castillo, D, González, J, Barril, S, Gutiérrez-Rodríguez, Y, Caballero, P, Alarcon, J, Peñafiel, J, Sanz-Santos, J, Blavia, R, Caupena, C, Segovia, P, Santos-Pérez, S, Ferrer-Artola, A, Badia, MB, Hereu, P, Fuentes, M, Montes-Worboys, A, Franquet, T, Luburich, P, Molina-Molina, M. Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial. EUROPEAN RESPIRATORY JOURNAL. 2025; 65(4)DOI:10.1183/13993003.02249-2024. PMID:40154560. IF:21.000(Q1/1D).